Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S; Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA). Pengo V, et al. Among authors: erba n. Circulation. 2009 Jun 9;119(22):2920-7. doi: 10.1161/CIRCULATIONAHA.108.823211. Epub 2009 May 26. Circulation. 2009. PMID: 19470892 Clinical Trial.
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Palareti G, et al. Among authors: erba n. Lancet. 1996 Aug 17;348(9025):423-8. doi: 10.1016/s0140-6736(96)01109-9. Lancet. 1996. PMID: 8709780
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).
Palareti G, Manotti C, DAngelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Leali N, Poggi M, Legnani C, Musolesi S, Coccheri S. Palareti G, et al. Among authors: erba n. Thromb Haemost. 1997 Dec;78(6):1438-43. Thromb Haemost. 1997. PMID: 9423791 Clinical Trial.
D-dimer testing to determine the duration of anticoagulation therapy.
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators. Palareti G, et al. N Engl J Med. 2006 Oct 26;355(17):1780-9. doi: 10.1056/NEJMoa054444. N Engl J Med. 2006. PMID: 17065639 Free article. Clinical Trial.
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples.
Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A, de Candia E, Montaruli B, Testa S, Barcellona D, Tripodi A; Participating Centres of Italian Federation of Thrombosis Centres (FCSA). Pengo V, et al. Among authors: erba n. J Thromb Haemost. 2007 May;5(5):925-30. doi: 10.1111/j.1538-7836.2007.02454.x. J Thromb Haemost. 2007. PMID: 17461926 Free article.
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S. Pengo V, et al. Among authors: erba n. J Thromb Haemost. 2010 Feb;8(2):237-42. doi: 10.1111/j.1538-7836.2009.03674.x. Epub 2009 Oct 30. J Thromb Haemost. 2010. PMID: 19874470 Free article.
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Palareti G; PROLONG Investigators; FCSA, Italian Federation of Anticoagulation Clinics. Cosmi B, et al. Thromb Haemost. 2010 Jun;103(6):1152-60. doi: 10.1160/TH09-11-0759. Epub 2010 Mar 29. Thromb Haemost. 2010. PMID: 20352167 Clinical Trial.
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA).
Pengo V, Denas G, Bison E, Banzato A, Jose SP, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A, De Candia E, Montaruli B, Marietta M, Testa S, Barcellona D, Tripodi A; Italian Federation of Thrombosis Centers (FCSA). Pengo V, et al. Among authors: erba n. Thromb Res. 2010 Aug;126(2):150-3. doi: 10.1016/j.thromres.2010.05.018. Epub 2010 Jun 9. Thromb Res. 2010. PMID: 20542544
35 results